Global Industry Analysts, Inc., Sep 2010, Pages: 487
Anticoagulants - Global Strategic Business Report This report analyzes the worldwide markets for Anticoagulants in US$ Million by the following segments : Oral Anticoagulants, and Injectable
Frost & Sullivan, Nov 1997
U.S. Anticoagulant and Thrombolytic Pharmaceuticals Markets
This market has not yet reached its maturity, and new products, such as low molecular weight heparins and thrombolytic
Espicom Business Intelligence Ltd, May 2011, Pages: 396
the rising number of people with diabetes globally.
Infectious diseases - the market is forecast to show improvement in 2011 after declines in 2010 that were mainly the result of unfavourable comparisons
Espicom Business Intelligence Ltd, May 2011, Pages: 396
. The underlying market fundamentals remain strong, given the rising number of people with diabetes globally.
Infectious diseases - the market is forecast to show improvement in 2011 after declines in 2010
MP Advisors, Jan 2012, Pages: 109
Global Biopharma Outlook 2012 - Major US and EU Pharma Global Biopharma Outlook 2012 –Major US and EU Pharma
Unarguably 2011 was one of the very good years for the global Pharma industry
Global Industry Analysts, Inc., Aug 2011, Pages: 188
Sepsis Therapeutics - Global Strategic Business Report This report analyzes the worldwide markets for Sepsis Therapeutics in US$ Million. Analytics refer to sales of drugs used in the direct
GlobalData, Oct 2010, Pages: 25
devices.
- Review of key industry trends and events which are likely to impact and change the dynamics of the global cardiovascular devices markets in the long run.
- In-depth analysis of the studies
Biophoenix Limited, July 2009, Pages: 275
to enter the biologics market, a segment which is uniquely driven by unmet needs, commands premium prices, and continues to outperform the global pharma market.
This new and timely report analyzes
Global Industry Analysts, Inc., Sep 2011, Pages: 126
Therapeutic Apheresis - Global Strategic Business Report This report analyzes the US market for Therapeutic Apheresis in US$ Thousand by the following procedures: Photopheresis, Plasmapheresis
GlobalData, Jan 2012, Pages: 75
GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source
GlobalData, Dec 2010, Pages: 42
Atrial Fibrillation Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Atrial Fibrillation Therapeutics – Pipeline Assessment and Market Forecasts to 2017
Summary
Global
